Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?
Sina BurthMona OhmannDorothea KronsteinerMeinhard KieserSarah LöwLars RiedemannMona LaibleAnne BerberichKatharina DrüschlerTimolaos RizosAntje WickFrank WinklerWolfgang WickSimon NagelPublished in: Journal of neuro-oncology (2021)
AC did not seem to influence the incidence of ICH in patients with glioblastoma or brain metastases within follow up of just under 9 months.